Rush Hymenoptera venom immunotherapy: A safe and practical protocol for high-risk patients
- 1 December 2002
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (6) , 928-933
- https://doi.org/10.1067/mai.2002.129124
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Reduction of side‐effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine:a double‐blind, placebo‐controlled trialAllergy, 2000
- Survey of patients after discontinuing venom immunotherapyJournal of Allergy and Clinical Immunology, 2000
- Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patientsJournal of Allergy and Clinical Immunology, 1998
- Discontinuing venom immunotherapy: Extended observationsJournal of Allergy and Clinical Immunology, 1998
- Discontinuation of yellow jacket venom immunotherapy: Follow-up of 75 patients by means of deliberate sting challengeJournal of Allergy and Clinical Immunology, 1997
- Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trialJournal of Allergy and Clinical Immunology, 1997
- The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergyClinical and Experimental Allergy, 1995
- Rapid Hymenoptera venom immunotherapy: comparative safety of three protocolsClinical and Experimental Allergy, 1993
- Reduction of side effects from rush‐immunotherapy with honey bee venom by pretreatment with terfenadineClinical and Experimental Allergy, 1992
- Honeybee venom allergy: Results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patientsJournal of Allergy and Clinical Immunology, 1991